← Browse by Condition
Medical Condition

hepatocellulcar carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07238881 Phase 2
Recruiting

Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment

Enrollment
30 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →